Skip to main content

Articles

Page 52 of 70

  1. Localization of the tumor bed of breast cancer is crucial for accurate planning of boost irradiation. Lumpectomy cavity and surgical clips provide localizing information about tumor bed. However, defining the ...

    Authors: Oyeon Cho, Mison Chun, Young Taek Oh, Mi Hwa Kim, Hae Jin Park, Jae Sung Heo and O Kyu Noh
    Citation: Radiation Oncology 2013 8:163
  2. This retrospective study investigated the outcome of patients with brain metastases after radiosurgery with special emphasis on prognostic impact of visible intratumoral necrosis on survival and local control.

    Authors: Kristina Martens, Thekla Meyners, Dirk Rades, Volker Tronnier, Matteo Mario Bonsanto, Dirk Petersen, Jürgen Dunst and Kathrin Dellas
    Citation: Radiation Oncology 2013 8:162
  3. First, to evaluate outcome, the benefit of concurrent chemotherapy and prognostic factors in a cohort of sixty-four high-grade glioma patients who underwent a second course of radiation therapy at progression....

    Authors: Felix Scholtyssek, Isabella Zwiener, Annika Schlamann, Clemens Seidel, Jürgen Meixensberger, Manfred Bauer, Karl-Titus Hoffmann, Stephanie E Combs, André O von Bueren, Rolf-Dieter Kortmann and Klaus Müller
    Citation: Radiation Oncology 2013 8:161
  4. Although capecitabine has theoretical advantages in the pharmacokinetics, such as higher intratumoral and lower systemic concentration, relative to bolus 5-fluorouracil (5-FU), outcomes of chemoradiotherapy (C...

    Authors: Yeon-Joo Kim, Woo Jin Lee, Sang Myung Woo, Tae Hyun Kim, Sung Sik Han, Bo Hyun Kim, Sung Ho Moon, Sang Soo Kim, Young Hwan Koh, Sang Jae Park, Joo Young Kim, Dae Yong Kim and Joong Won Park
    Citation: Radiation Oncology 2013 8:160
  5. Hormone-resistant (HR) prostate cancers are highly aggressive and respond poorly to treatment. IL-6/STAT3 signaling has been identified to link with the transition of HR and aggressive tumor behavior. The role...

    Authors: Chun-Te Wu, Miao-Fen Chen, Wen-Cheng Chen and Ching-Chuan Hsieh
    Citation: Radiation Oncology 2013 8:159
  6. Stereotactic body radiotherapy and radiosurgery are rapidly emerging treatment options for both malignant and benign spine tumors. Proper institutional credentialing by physicians and medical physicists as wel...

    Authors: Peter C Gerszten, Arjun Sahgal, Jason P Sheehan, Ronald Kersh, Stephanie Chen, John C Flickinger, Mubina Quader, Daniel Fahim, Inga Grills, John H Shin, Brian Winey, Kevin Oh, Reinhart A Sweeney and Matthias Guckenberger
    Citation: Radiation Oncology 2013 8:158
  7. To evaluate the efficacy and toxicity of fractionated stereotactic radiotherapy (FSRT) in patients with residual nasopharyngeal carcinoma (NPC).

    Authors: Feng Liu, Jian-ping Xiao, Guo-zhen Xu, Li Gao, Ying-jie Xu, Ye Zhang, Xue-song Jiang, Jun-lin Yi, Jing-wei Luo, Xiao-dong Huang, Fu-kui Huan, Hao Fang, Bao Wan and Ye-xiong Li
    Citation: Radiation Oncology 2013 8:157
  8. The incidence of oligometastases to the brain in good performance status patients is increasing due to improvements in systemic therapy and MRI screening, but specific management pathways are often lacking.

    Authors: Jillian Maclean, Naomi Fersht, Mausam Singhera, Paul Mulholland, Orla McKee, Neil Kitchen and Susan C Short
    Citation: Radiation Oncology 2013 8:156
  9. To evaluate the role of γ-H2AX in peripheral blood lymphocytes (PBLs) as a predictive biomarker of the severity of oral mucositis (OM) in head and neck cancer (HNC) patients with receiving radiotherapy.

    Authors: Ping Li, Cheng-run Du, Wen-cai Xu, Ze-liang Shi, Qing Zhang, Zhao-bin Li and Shen Fu
    Citation: Radiation Oncology 2013 8:155
  10. Intensity modulated radiotherapy for head and neck cancer necessitates accurate definition of organs at risk (OAR) and clinical target volumes (CTV). This crucial step is time consuming and prone to inter- and...

    Authors: Jean-François Daisne and Andreas Blumhofer
    Citation: Radiation Oncology 2013 8:154
  11. The purpose of this study was to evaluate the impact of Cone Beam CT (CBCT) based setup correction on total dose distributions in fractionated frameless stereotactic radiation therapy of intracranial lesions.

    Authors: Petra Maria Haertl, Rainer Loeschel, Natalia Repp, Fabian Pohl, Oliver Koelbl and Barbara Dobler
    Citation: Radiation Oncology 2013 8:153
  12. This study was to compare radiotherapy treatment planning and treatment outcomes following three-dimensional conformal radiotherapy (3DCRT) and intensity-modulated radiotherapy (IMRT) in stage I-II natural kil...

    Authors: Qianwen Shen, Xuejun Ma, Weigang Hu, Lanfei Chen, Juan Huang and Ye Guo
    Citation: Radiation Oncology 2013 8:152
  13. Early stage breast cancer patients are long-term survivors and finding techniques that may lower acute and late radiotherapy-induced toxicity is crucial. We compared dosimetry of wedged tangential fields (W-TF...

    Authors: Thomas Mulliez, Bruno Speleers, Indira Madani, Werner De Gersem, Liv Veldeman and Wilfried De Neve
    Citation: Radiation Oncology 2013 8:151
  14. To investigate the feasibility and dosimetric improvements of a novel technique to temporarily displace critical structures in the pelvis and abdomen from tumor during high-dose radiotherapy.

    Authors: Evangelia Katsoulakis, Stephen B Solomon, Majid Maybody, Douglas Housman, Greg Niyazov, Nadeem Riaz, Michael Lovelock, Daniel E Spratt, Joseph P Erinjeri, Raymond H Thornton and Yoshiya Yamada
    Citation: Radiation Oncology 2013 8:150
  15. The main aim of the current study was to assess the dosimetric accuracy and clinical quality of volumetric modulated arc therapy (VMAT) plans for stereotactic (stage I) and conventional (stage III) lung cancer...

    Authors: Petra S Kroon, Sandra Hol and Marion Essers
    Citation: Radiation Oncology 2013 8:149
  16. To assess the efficacy and safety of stereotactic body radiotherapy (SBRT) in patients with either unresectable locally advanced pancreatic adenocarcinoma or by locally recurrent disease after surgery.

    Authors: Angelo Tozzi, Tiziana Comito, Filippo Alongi, Pierina Navarria, Cristina Iftode, Pietro Mancosu, Giacomo Reggiori, Elena Clerici, Lorenza Rimassa, Alessandro Zerbi, Antonella Fogliata, Luca Cozzi, Stefano Tomatis and Marta Scorsetti
    Citation: Radiation Oncology 2013 8:148
  17. Primary cutaneous follicle center lymphoma is an indolent primary cutaneous B-cell lymphoma originating from the follicle center cells, composed of a combination of centrocytes (small and large cleaved cells) ...

    Authors: Romana Ceovic, Ivana Jovanovic, Kresimir Kostovic, Jaka Rados, Snjezana Dotlic, Ivo Radman, Sandra Marinovic Kulisic and Davorin Loncaric
    Citation: Radiation Oncology 2013 8:147
  18. In a previous report, we compared the conformity of robust intensity-modulated proton therapy (IMPT) plans with that of helical tomotherapy plans for re-irradiations of head and neck carcinomas using a fixed s...

    Authors: Martin Stuschke, Andreas Kaiser, Jehad Abu Jawad, Christoph Pöttgen, Sabine Levegrün and Jonathan Farr
    Citation: Radiation Oncology 2013 8:145
  19. Post-operative radiotherapy (PORT) for stage IIIA completely-resected non-small cell lung cancer (CR-NSCLC) has been shown to improve local control; however, it is unclear that this translates into a survival ...

    Authors: Abigail T Berman, Boon-Keng Kevin Teo, Derek Dolney, Samuel Swisher-McClure, Kambiz Shahnazi, Stefan Both and Ramesh Rengan
    Citation: Radiation Oncology 2013 8:144
  20. We evaluated whether or not PET or PET/CT using L-methyl-[11C]-methionine (MET) can allow for the early prediction of local recurrence and metastasis, as well as the prognosis (disease-specific survival), in p...

    Authors: Sachiko Toubaru, Kyosan Yoshikawa, Seiya Ohashi, Katsuyuki Tanimoto, Azusa Hasegawa, Koji Kawaguchi, Tsuneo Saga and Tadashi Kamada
    Citation: Radiation Oncology 2013 8:143
  21. To evaluate the efficacy of proton beam therapy (PBT) for pediatric patients with advanced neuroblastoma.

    Authors: Yoshiko Oshiro, Masashi Mizumoto, Toshiyuki Okumura, Shinji Sugahara, Takashi Fukushima, Hitoshi Ishikawa, Tomohei Nakao, Takayuki Hashimoto, Koji Tsuboi, Haruo Ohkawa, Michio Kaneko and Hideyuki Sakurai
    Citation: Radiation Oncology 2013 8:142
  22. The lack of sensitive biocompatible particle track detectors has so far limited parallel detection of physical energy deposition and biological response. Fluorescent nuclear track detectors (FNTDs) based on Al2O3

    Authors: Martin Niklas, Steffen Greilich, Claudius Melzig, Mark S Akselrod, Jürgen Debus, Oliver Jäkel and Amir Abdollahi
    Citation: Radiation Oncology 2013 8:141
  23. The accuracy of the two dose calculation engines available for RapidArc planning (both released for clinical use) is investigated in comparison to the COMPASS data.

    Authors: Murugesan Kathirvel, Shanmuga Subramanian, Alessandro Clivio, Gandhi Arun, Antonella Fogliata, Giorgia Nicolini, Vellaiyan Subramani, Shanmugam Thirumalai Swamy, Eugenio Vanetti and Luca Cozzi
    Citation: Radiation Oncology 2013 8:140
  24. To investigate the three-dimensional (3D) distribution patterns of clinically metastatic (positive) lymph nodes on pretreatment computed tomography (CT)/magnetic resonance imaging (MRI) images of patients with...

    Authors: Goro Kasuya, Takafumi Toita, Kazuhisa Furutani, Takeshi Kodaira, Tatsuya Ohno, Yuko Kaneyasu, Ryouichi Yoshimura, Takashi Uno, Akira Yogi, Satoshi Ishikura and Masahiro Hiraoka
    Citation: Radiation Oncology 2013 8:139
  25. In radiation oncology recurrence analysis is an important part in the evaluation process and clinical quality assurance of treatment concepts. With the example of 9 patients with locally advanced pancreatic ca...

    Authors: Kerstin A Kessel, Daniel Habermehl, Andreas Jäger, Ralf O Floca, Lanlan Zhang, Rolf Bendl, Jürgen Debus and Stephanie E Combs
    Citation: Radiation Oncology 2013 8:138
  26. To evaluate the efficacy of hypofractionated radiotherapy (HyRT) with or without image guided radiotherapy (IGRT) in intermediate risk prostate cancer.

    Authors: Maurizio Valeriani, Stefano Bracci, Mattia Falchetto Osti, Teresa Falco, Linda Agolli, Vitaliana De Sanctis and Riccardo Maurizi Enrici
    Citation: Radiation Oncology 2013 8:137
  27. To quantify the development of radiation neuropathy in corneal subbasal nerve plexus (SNP) after plaque brachytherapy, and the subsequent regeneration of SNP micromorphology and corneal sensation.

    Authors: Andrey Zhivov, Karsten Winter, Sabine Peschel, Oliver Stachs, Andreas Wree, Guido Hildebrandt and Rudolf Guthoff
    Citation: Radiation Oncology 2013 8:136
  28. Hypofractionated Radiosurgery (HR) is a therapeutic option for delivering partial brain radiotherapy (RT) to large brain metastases or resection cavities otherwise not amenable to single fraction radiosurgery ...

    Authors: Bree R Eaton, Brian Gebhardt, Roshan Prabhu, Hui-Kuo Shu, Walter J Curran Jr and Ian Crocker
    Citation: Radiation Oncology 2013 8:135
  29. The application of spacer gel represents a promising approach to reliably spare the rectal frontal wall during particle therapy (IJROBP 76:1251-1258, 2010). In order to qualify the spacer gel for the clinical ...

    Authors: Antoni Ruciński, Julia Bauer, Patrick Campbell, Stephan Brons, Daniel Unholtz, Gregor Habl, Klaus Herfarth, Jürgen Debus, Christoph Bert, Katia Parodi, Oliver Jäkel and Thomas Haberer
    Citation: Radiation Oncology 2013 8:134
  30. The removal of the flattening filter (FF) leads to non-uniform fluence distribution with a considerable increase in dose rate. It is possible to adapt FFF beams (flattening-filter-free) in 3D conformal radiati...

    Authors: Matthias Kretschmer, Marcello Sabatino, Arne Blechschmidt, Sebastian Heyden, Bernd Grünberg and Florian Würschmidt
    Citation: Radiation Oncology 2013 8:133
  31. The objective was to analyze locoregional (LR) failure patterns in patients with head-and-neck cancer (HNC) treated using intensity-modulated radiotherapy (IMRT) with whole salivary gland-sparing: parotid (PG)...

    Authors: Enrique Chajon, Caroline Lafond, Guillaume Louvel, Joël Castelli, Danièle Williaume, Olivier Henry, Franck Jégoux, Elodie Vauléon, Jean-Pierre Manens, Elisabeth Le Prisé and Renaud de Crevoisier
    Citation: Radiation Oncology 2013 8:132
  32. Breast cancer is the second most common cause of brain metastases in the United States. Although breast cancer induced brain metastases represent an incurable condition, some patients experience prolonged surv...

    Authors: Jerry J Jaboin, Daniel J Ferraro, Todd A DeWees, Keith M Rich, Michael R Chicoine, Joshua L Dowling, David B Mansur, Robert E Drzymala, Joseph R Simpson, William J Magnuson, Anushka H Patel and Imran Zoberi
    Citation: Radiation Oncology 2013 8:131
  33. Neoadjuvant chemoradiation has become the standard treatment in locally advanced rectal cancer (LARC) and improves local control. This study explored the feasibility of an intensified chemoradiation treatment ...

    Authors: Ji Zhu, Weilie Gu, Peng Lian, Weiqi Sheng, Gang Cai, Debing Shi, Sanjun Cai and Zhen Zhang
    Citation: Radiation Oncology 2013 8:130
  34. The purpose of this study was to demonstrate how magnetic resonance imaging (MRI) patient position protocols influence registration quality in patients with oropharyngeal cancer undergoing radical radiotherapy...

    Authors: Scott Hanvey, Mark McJury, Lye Mun Tho, Martin Glegg, Maureen Thomson, Derek Grose, Allan James, Mohammed Rizwanullah, Claire Paterson and John Foster
    Citation: Radiation Oncology 2013 8:129
  35. To examine the role of radiotherapy (RT) in uterine leiomyosarcomas (LMS) and to determine the patient population who may benefit from RT.

    Authors: Philip Wong, Kathy Han, Jenna Sykes, Charles Catton, Stephane Laframboise, Anthony Fyles, Lee Manchul, Wilfred Levin and Michael Milosevic
    Citation: Radiation Oncology 2013 8:128
  36. A multidisciplinary and multi-institutional working group applied the Failure Mode and Effects Analysis (FMEA) approach to the actively scanned proton beam radiotherapy process implemented at CNAO (Centro Nazi...

    Authors: Marie Claire Cantone, Mario Ciocca, Francesco Dionisi, Piero Fossati, Stefano Lorentini, Marco Krengli, Silvia Molinelli, Roberto Orecchia, Marco Schwarz, Ivan Veronese and Viviana Vitolo
    Citation: Radiation Oncology 2013 8:127
  37. The use of magnetic resonance (MR) imaging as a part of preparation for radiotherapy is increasing. For delineation of the prostate several publications have shown decreased delineation variability using MR co...

    Authors: Tufve Nyholm, Joakim Jonsson, Karin Söderström, Per Bergström, Andreas Carlberg, Gunilla Frykholm, Claus F Behrens, Poul Flemming Geertsen, Redas Trepiakas, Scott Hanvey, Azmat Sadozye, Jawaher Ansari, Hazel McCallum, John Frew, Rhona McMenemin and Björn Zackrisson
    Citation: Radiation Oncology 2013 8:126
  38. Biomarkers are needed to individualize cancer radiation treatment. Therefore, we have investigated the association between various risk factors, including single nucleotide polymorphisms (SNPs) in candidate ge...

    Authors: Ghazi Alsbeih, Medhat El-Sebaie, Najla Al-Harbi, Khaled Al-Hadyan, Mohamed Shoukri and Nasser Al-Rajhi
    Citation: Radiation Oncology 2013 8:125

    The Retraction Note to this article has been published in Radiation Oncology 2018 13:79

  39. To identify dose-volume parameters predictive for severity of acute esophagitis (CTC > grade 2) in locally-advanced non small-cell lung cancer (LA-NSCLC) patients treated with neoadjuvant concurrent hyperfract...

    Authors: Farkhad Manapov, Susanna Sepe, Maximilian Niyazi, Claus Belka, Godehard Friedel and Wilfried Budach
    Citation: Radiation Oncology 2013 8:122
  40. The combined predictive value of plasma uric acid and primary tumor volume in nasopharyngeal carcinoma (NPC) patients receiving intensity modulated radiation therapy (IMRT) has not yet been determined.

    Authors: Hui Lin, Huan-Xin Lin, Nan Ge, Hong-Zhi Wang, Rui Sun and Wei-Han Hu
    Citation: Radiation Oncology 2013 8:121
  41. The purpose of this study is to investigate the dosimetric characteristics of volumetric modulated arc therapy (VMAT) with flattening filter-free (FFF) beams and assess the role of VMAT in the treatment of adv...

    Authors: Mingzan Zhuang, Tuodan Zhang, Zhijian Chen, Zhixiong Lin, Derui Li, Xun Peng, Qingchun Qiu and Renhua Wu
    Citation: Radiation Oncology 2013 8:120
  42. To evaluate the prognostic value of axillary lymph node ratio (LNR) as compared to the number of involved nodes (pN stage) in patients with axillary lymph node-positive breast cancer treated with mastectomy wi...

    Authors: San-Gang Wu, Yong Chen, Jia-Yuan Sun, Feng-Yan Li, Qin Lin, Huan-Xin Lin and Zhen-Yu He
    Citation: Radiation Oncology 2013 8:119
  43. Stereotactic body radiotherapy (SBRT) may yield disease control for prostate cancer in a brief, hypofractionated treatment regimen without increasing treatment toxicity. Our report presents a 6-year update fro...

    Authors: Alan J Katz, Michael Santoro, Fred Diblasio and Richard Ashley
    Citation: Radiation Oncology 2013 8:118
  44. Codon 72 (Arg/Pro), the most frequently studied single nucleotide polymorphism (SNP) of p53 to date, is associated with the ability of the gene to induce cell apoptosis. The PI3K/Akt pathway plays an essential...

    Authors: Xiaoxue Xie, Hui Wang, Hekun Jin, Shuyu Ouyang, Jumei Zhou, Jun Hu, Xuping Xi, Junming Luo, Yingying Zhang and Bingqiang Hu
    Citation: Radiation Oncology 2013 8:117
  45. Though postoperative radiation for esophageal squamous cell carcinoma is offered in selected cases, there is conflicting evidence as to whether it improves overall survival (OS). A retrospective investigation ...

    Authors: Yaping Xu, Jinshi Liu, Xianghui Du, Xiaojiang Sun, Yuanda Zheng, Jianxiang Chen, Bo Li, Wei Liu, Hao Jiang and Weimin Mao
    Citation: Radiation Oncology 2013 8:116
  46. To report the clinical outcome of high dose rate brachytherapy as sole treatment for clinically localised prostate cancer.

    Authors: Nikolaos Tselis, Ulf W Tunn, Georgios Chatzikonstantinou, Natasa Milickovic, Dimos Baltas, Markus Ratka and Nikolaos Zamboglou
    Citation: Radiation Oncology 2013 8:115

Annual Journal Metrics

  • 2022 Citation Impact
    3.6 - 2-year Impact Factor
    3.8 - 5-year Impact Factor
    1.370 - SNIP (Source Normalized Impact per Paper)
    1.037 - SJR (SCImago Journal Rank)

    2023 Speed
    16 days submission to first editorial decision for all manuscripts (Median)
    132 days submission to accept (Median)

    2023 Usage 
    1,958,690 downloads
    605 Altmetric mentions